Jefferies Group’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Jefferies Group’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-300	Closed	-$10.4K	–	1969
2022 Q1	$10.4K	Buy	+300	New	+$8.97K	﹤0.01%	1464
2021 Q4	–	Sell	-50,000	Closed	-$1.27M	–	2138
2021 Q3	$1.27M	Hold	50,000	–	–	0.01%	903
2021 Q2	$1.75M	Buy	+50,000	New	+$1.95M	0.01%	792
2020 Q3	–	Sell	-67,000	Closed	-$4.23K	–	1620
2020 Q2	$4.23K	Buy	+67,000	New	+$4.6M	0.05%	316
2019 Q4	–	Sell	-95,000	Closed	-$4.61M	–	3155
2019 Q3	$4.61M	Sell	95,000 -31,400	-25%	-$1.64M	0.04%	566
2019 Q2	$6.65M	Buy	126,400 +75,000	+146%	+$4.31M	0.05%	353
2019 Q1	$2.72M	Sell	51,400 -18,800	-27%	-$924K	0.02%	739
2018 Q4	$2.88M	Sell	70,200 -148,600	-68%	-$5.57M	0.02%	649
2018 Q3	$8.31M	Sell	218,800 -49,500	-18%	-$2.19M	0.05%	329
2018 Q2	$12.1M	Buy	+268,300	New	+$12.2M	0.07%	217
2016 Q2	–	Sell	-30,000	Closed	-$476K	–	2527
2016 Q1	$476K	Buy	+30,000	New	+$533K	﹤0.01%	1481

Other funds holding GBT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Jefferies Group's GBT Position: Q3 2022 in Review

Jefferies Group opened a new position in Global Blood Therapeutics, Inc. (GBT) in Q3 2022: 46,344 shares worth $3.16M. The stake represents 0.03% of the portfolio and ranks #465 among its holdings. This is a return to the name: Jefferies Group previously reported a position in GBT as recently as Q1 2022.

Jefferies Group first reported a position in GBT in Q3 2016 and has held it in 13 quarters since. The position peaked at $3.48M in Q1 2020. 247 funds tracked by Wall St. Rank hold GBT as of Q3 2022.

Jefferies Group held 46,344 shares of Global Blood Therapeutics, Inc. worth $3.16M as of Q3 2022.
Global Blood Therapeutics, Inc. was a new Jefferies Group position in Q3 2022.
Global Blood Therapeutics, Inc. made up 0.03% of Jefferies Group's portfolio in Q3 2022, its #465 holding.
Jefferies Group first reported a position in Global Blood Therapeutics, Inc. in Q3 2016 and has held it in 13 quarters since.
Jefferies Group's Global Blood Therapeutics, Inc. position peaked at $3.48M in Q1 2020.
247 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.